The Biologic and Radiopharmaceutical Drugs Directorate (BRDD), previously known as the Biologics and Genetic Therapies Directorate (BGTD), is a Canadian regulatory directorate based in Ottawa, Ontario. It is a subsidiary of the Health Products and Food Branch (HPFB) of Health Canada.[1]
History
In early 2020, the Biologics and Genetic Therapies Directorate changed its name to the Biologic and Radiopharmaceutical Drugs Directorate.[2]
Organization
BRDD is made up of several centres and offices:
- Centre for Biologics Evalution (CBE)
- Centre for Oncology, Radiopharmaceuticals and Research
Personnel
| Name | Position | Notes |
|---|---|---|
| Sophie Sommerer | Director General[3] | Marketed Health Products Directorate, Therapeutics Products Directorate (TPD), First Nations and Inuit Health Branch, Centre for Health Promotion (CHP), Strategic Initiatives and Innovations Directorate |
| Christopher Antonio | Manager, Office of Regulatory Affairs[4] | - |
| Léo Bouthillier | Director[5] | - |
| Agnes Klein | Senior Medical Advisor[6] | Drug Information Association (DIA) |
| Manon Poulin | Management Executive Assistant / Administrative Officer[7] | - |
| Julie Wallace | Manager, Office of Regulatory Affairs[8] | Biologics and Genetic Therapies Directorate |
| Lucia Zhang | Senior Clinical Evaluator[9][10] | American Society for Pharmacology and Experimental Therapeutics, American Society for Bone and Mineral Research |
Health Canada. (2020, October 20). Biologic and Radiopharmaceutical Drugs Directorate. Government of Canada. http://archive.today/2021.06.02-181514/https://www.canada.ca/en/health-canada/corporate/about-health-canada/branches-agencies/health-products-food-branch/biologic-radiopharmaceutical-drugs-directorate.html ↩︎
Biologic and Radiopharmaceutical Drugs Directorate Drug Submission Performance Annual Report Fiscal Year 2019-2020 - April 1 2019 – March 31 2020. (2020, July). Health Canada. https://publications.gc.ca/collections/collection_2020/sc-hc/H166-5-2020-eng.pdf ↩︎
Experience | Sophie Sommerer. LinkedIn. Retrieved February 24, 2024, from https://www.linkedin.com/in/sophie-sommerer-8845a513/details/experience/ ↩︎
Christopher Antonio · Health Canada · Manager. OpenGovCA. Retrieved November 26, 2023, from https://web.archive.org/web/20231126235401/https://opengovca.com/employee/christopher-antonio ↩︎
Rencheck, M. (2023, November 14). Monthly Communication Report - 928062-5776-33. Office of the Commissioner of Lobbying of Canada. http://archive.today/2023.11.26-232600/https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/cmmLgPblcVw?comlogId=507862 ↩︎
Agnes Klein. LinkedIn. Retrieved February 24, 2024, from https://www.linkedin.com/in/agnes-klein-98a1246/ ↩︎
Person Information - Manon L Poulin. (2020, October 10). Government of Canada. http://archive.today/2023.11.26-233233/https://new.geds-sage.gc.ca/en/GEDS/?pgid=015&dn=Q049TUFOT04uTC5QT1VMSU5ASEMtU0MuR0MuQ0EsT1U9REdPLUJERyxPVT1CUkRELURNQlIsT1U9SFBGQi1ER1BTQSxPVT1IQy1TQyxPPUdDLEM9Q0E= ↩︎
Experience | Julie Wallace. LinkedIn. Retrieved November 26, 2023, from http://archive.today/2023.11.26-234442/https://www.linkedin.com/in/julie-wallace-25371a14/details/experience/ ↩︎
Lucia Zhang. LinkedIn. Retrieved May 27, 2023, from http://archive.today/2023.05.27-053527/https://www.linkedin.com/in/lucia-zhang-53143226/ ↩︎
Lucia Zhang · Health Canada · Clinical Evaluator. OpenGovCa. Retrieved May 27, 2023, from https://web.archive.org/web/20230527053643/https://opengovca.com/employee/lucia-zhang ↩︎
